The Conquest of Cancer

We have harnessed the power of new technologies to identify genes involved in the development of cancers and forever change how we think about these diseases.

Written byPaul Marks
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For the first time since records have been kept, death rates from cancer in the United States have dropped--by some 2.6 percent between 1991 and 1995. These figures are encouraging when compared with cancer mortality rates recorded during the previous decade (1981-1990), which actually increased.

It is likely these successes result from several factors, including more effective methods of treating cancers; better, more widely used techniques to diagnose cancers early; and progress in the prevention of some cancers. Moreover, we have entered a period of unprecedented biological discovery. Perhaps most importantly, we have harnessed the power of new technologies to identify genes involved in the development of cancers and forever change how we think about these diseases.

Surgery, chemotherapy, and radiation therapy remain the mainstays of cancer treatment and continue to be improved. But today investigators are developing targeted cancer treatments, many of which home in on cancer cells while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies